A quiet beach path toward understanding ME/CFS — and toward the research that will end it.
This is a small, calm place for anyone whose life has been touched by
myalgic encephalomyelitis / chronic fatigue syndrome — people living
with it, the families who love them, and neighbours who simply want to
understand. Walk it slowly, like a sandy path over the dunes toward
the water. Everything here is written in plain words,
in short stretches, with places to rest.
You will find what this illness is, what daily life inside it asks of a
person, who is working on answers, and how to support that work if you
would like to.
One honest thing, right up front: this site never
collects money. There are no payment forms here and nothing for sale.
Every “give” button on this page takes you straight to a
charity’s own donation page — 100% of any gift goes
directly to the charity you choose. This site takes nothing
and touches nothing.
What is ME/CFS?
A serious, long-term illness — not tiredness, and not something a person can push through.
ME/CFS is a complex illness that affects the whole body. It often begins
after an infection, and it does not simply go away. People with ME/CFS
have far less capacity than they used to — for work, for family
life, sometimes for the smallest daily tasks — and ordinary rest
does not restore them the way sleep restores a healthy tired person.
The hallmark: post-exertional malaise (PEM)
The defining feature of ME/CFS is called post-exertional
malaise, or PEM. In everyday words: after even a small
effort — a shower, a short walk, a phone call, a visitor, a
hard conversation — symptoms get worse, not better.
Strangely, the crash often does not arrive right away. It may come
12 to 48 hours later, be far bigger than the effort that caused it,
and take days or weeks to ease. The National Institutes of Health
calls PEM “the hallmark of the disease,” in which
“even trivial amounts of activity result in a prolonged
exacerbation of symptoms and a further reduction in function.”
This is why “just push through it” is harmful advice here.
Exertion is not the cure for this illness. For many people, it is the
thing that makes it worse.
It is not one size
ME/CFS runs along a spectrum. Where a person sits on it can change over time:
Mild
Still working or studying, but at a cost — evenings and weekends given over to recovery.
Moderate
Work or school reduced or lost. Leaving the house takes planning, and is paid for afterwards.
Severe
Mostly housebound. Basic self-care — washing, dressing, a short conversation — can use up the whole day’s capacity.
Very severe
Bedbound, sometimes for years. Light, sound, and touch can be painful. Some people cannot speak, swallow easily, or tolerate visitors at all.
3.3 million
Up to 3.3 million people in the United States are estimated to live with ME/CFS.
Source: U.S. Centers for Disease Control and Prevention (CDC)
9 in 10
More than 9 in 10 people with ME/CFS have never been diagnosed by a doctor. Most are navigating this alone, without a name for it.
Source: CDC
1 in 4
About 1 in 4 people with ME/CFS are confined to bed at some point in their illness; many never regain the level of life they had before.
Source: CDC and National Institutes of Health (NIH)
None — yet
There is still no diagnostic test and no FDA-approved treatment for ME/CFS. Care today means managing symptoms and protecting energy.
Source: NIH, in those words
Worldwide, the honest answer is that no one has counted properly.
Estimates range from 17 million to more than 65 million people —
and a widely quoted figure of 17–24 million was shown in 2025 to
rest on a citation mistake. That uncertainty is itself part of the
story: an illness this common has never received the attention, or the
counting, it deserves.
In recent years, Long COVID has brought many new people to this same
door. In clinic studies, about half of people with Long COVID meet the
criteria for ME/CFS. In the large U.S. RECOVER study, 4.5% of adults
who had been infected met ME/CFS criteria, compared with 0.6% of those
never infected. The research below matters for both communities.
Living inside it
When energy is scarce and overspending it causes harm, rest stops being laziness. It becomes medicine.
Pacing: the daily discipline
Because of PEM, the central skill of living with ME/CFS is
pacing — spending energy slowly and deliberately,
the way you might spend money you cannot earn back. Patient advocates
sum it up as Stop, Rest, Pace:
Stop — don’t push through warning signs. Stop while you still feel you could do a little more.
Rest — real rest, lying down in quiet and low light, before and after anything demanding — not rest as a reward afterwards.
Pace — break every task into small pieces, with rests in between. Alternate kinds of effort: body, mind, senses, feelings.
Pacing is not a cure. It is how people protect the life they have left
from getting smaller. A good day is not a sign of recovery to spend
freely — it is often borrowed against the days after.
For the people who love them
Families witness this illness at close range, for years. If someone in
your life has ME/CFS, these small things carry more weight than they
might seem to:
Believe the crash, even when it arrives two days later. The delay is the disease, not an excuse.
Keep invitations open, without keeping score. A cancelled plan is a symptom, not a rejection. Being asked still matters.
Make visits easy to survive. Short, quiet, seated or lying down, scent-free, and easy to end without apology.
Offer specific help. “A meal on Tuesday” or “I’ll make that phone call” is easier to accept than “let me know.”
Let them spend their best hours on what they choose. Energy spent on a grandchild’s visit may mean a quiet week after. That trade is theirs to make.
And for caregivers themselves: carrying this alongside someone, year
after year, is its own burden. Research on families of people with
ME/CFS finds partners and parents often work less and develop health
problems of their own. Looking after yourself is part of looking after
them.
The research
Talented people are working on this. There are simply far too few of them, with far too little money.
ME/CFS research is carried by a small number of university centres and
the charities that fund them. Much of it exists because private donors
paid for it when public funding did not. Centres named in the research
behind this page include:
Stanford University — Ronald W. Davis, PhD
Searching for a diagnostic biomarker and studying the most severely ill patients. Stanford’s ME/CFS centre has been funded almost entirely by donors through the Open Medicine Foundation.
Cornell University — Maureen Hanson, PhD
Studying metabolism and what happens in the body during exercise and exertion. One of three centres funded by an NIH Collaborative Research Center grant in 2017 ($9.4 million over five years).
Columbia University — W. Ian Lipkin, MD
The Center for Solutions for ME/CFS: infection, the immune system, and the gut. NIH-funded in 2017 at $9.6 million over five years.
Jackson Laboratory — Derya Unutmaz, MD
Profiling the immune system, cell by cell, to find what differs in ME/CFS. NIH-funded in 2017 at $10.5 million over five years.
Harvard-affiliated hospitals — Wenzhong Xiao, PhD, and David Systrom, MD
Studying why exertion fails the body in ME/CFS, and running treatment trials. Also funded by donors through the Open Medicine Foundation.
The Open Medicine Foundation network
Six collaborative research centres — Harvard, Stanford, Uppsala, Montreal, Melbourne, and a computational centre — sharing data toward diagnostics, treatments, and a cure.
Proof that funding works
In August 2025, DecodeME at the University of Edinburgh — the
largest ME/CFS study ever run, with 15,579 people with ME/CFS and
259,909 controls — reported eight places in the genome
significantly linked to ME/CFS, pointing at the immune and nervous
systems. It is early work, released as a preprint that had not yet
completed peer review — but it is the first solid genetic foothold
this illness has ever had, and it happened because the study was funded.
Small grants multiply, too. Solve M.E.’s Ramsay Research Grants
have invested over $1.6 million in early-stage researchers — and
those researchers went on to win nearly $105 million in further
funding, a return of about 66 to 1.
The honest problem: the money is not there
The National Institutes of Health spent roughly $13 million a
year on ME/CFS in 2022–24 — for an illness the CDC
estimates costs the U.S. economy $18 to $51 billion a year
in medical costs and lost income. Two separate analyses, using
different measures, each ranked ME/CFS as the most underfunded NIH
category relative to its disease burden — one found it receives
about 7% of burden-commensurate funding; a 2026 analysis, measuring
years lived with disability, found less than 1%.
Average yearly NIH research funding, by condition
Per person, that works out to roughly $4 per patient per year
for ME/CFS, against about $124 for multiple sclerosis and $243 for
Parkinson’s.
Comparison figures as compiled by CrunchME from NIH RCDC data — an advocacy presentation of public funding data, shown here to give the scale of the gap.
This is the gap private giving quietly fills. The Open Medicine
Foundation alone has raised more than $65 million since
2012 and funded 70 studies and projects —
much of the science above exists because ordinary donors, many of them
patients and their families, paid for it.
Latest from the research
New studies, trials, and funding — added as they come. Plain words and honest labels: an announcement is not a result, and early research is not a cure.
November 2026
A planned trial aimed at the crash after effort
Two companies — ChronicleBio and Prolong Pharmaceuticals — have announced plans for a Phase 2a trial of PP-007, a treatment given by IV that aims to help oxygen reach the body’s tissues and shorten recovery from post-exertional malaise, the crash that follows even small effort. The trial would enroll at least 40 people with ME/CFS, with first dosing expected in mid-2027. This is the announcement of a planned trial, not a result — the treatment has not been tested in ME/CFS patients yet, and there is still no approved treatment for this illness. But a trial aimed squarely at PEM is a sign of where the research is heading.
Four established charities, four different jobs. Each button takes you to that charity’s own donation page.
How giving works here: this site receives no money,
holds no money, and takes no percentage — ever. You give directly
to the charity you choose, on their own page, and your tax receipt
comes from them. If you would like your gift to carry a name, each
charity offers a tribute option on its donation page — look for
“tribute” or “dedicate this donation.”
Solve M.E.
Advocacy plus seed research grants. Solve works to make ME/CFS “widely understood, diagnosable, and treatable” — funding early researchers through its Ramsay grants, running a patient registry, and pressing for public funding.
Registered 501(c)(3) · EIN 56-1683450 · Offers tribute & memorial gifts and monthly giving
Pure research fundraising. OMF raises money for its network of collaborative research centres — more than $65 million raised since 2012, funding 70 studies and projects toward diagnostics, treatments, and a cure.
Right now: during Triple Giving November, all gifts to OMF are tripled, up to $500,000, through December 1, 2026.
Registered 501(c)(3) · Offers tribute gifts — choose “Dedicate this donation” on their page
Clinical care plus education. A nonprofit centre of excellence in Salt Lake City that treats patients, runs research and trials, and teaches doctors and patients alike — including a free Clinical Care Guide shared in 2025.
Registered 501(c)(3) nonprofit · Donations support care, research, and free education
Patient-led advocacy. A worldwide network of patients, families, and allies fighting for research funding, medical education, and public awareness — the movement behind #MillionsMissing and the #StopRestPace pacing campaign.
Patient-led advocacy network · Donations fund advocacy and education, not research grants
No money to give? You can still move the research.
Both Solve M.E. and OMF run patient registries — the
unHide Registry
and OMF’s StudyME — that connect people living with ME/CFS
to studies that need them. And simply understanding PEM, and believing
the person in front of you, is a form of support this community has
been denied for decades.
Why the name
This site carries Pat’s name because her family watched, over
many years, what this illness does to a life — and what it does
to the people standing beside that life.
What her family wanted was simple: a path that points
other families toward understanding, and toward the research that
will one day end this.
So her name marks the start of the path, the way names so often are in this field
— a family’s way of saying: we saw it, it matters, and
nobody should walk it unseen. The path itself belongs to everyone
on it.
In her own words — coming only if Pat wishes.
This space is reserved for Pat’s own words, in her own time, only if she ever chooses to share them. Until then, it stays quietly empty — as it should.
Keep learning
A short shelf, chosen carefully. Take one thing at a time.
Watch: Unrest (2017)
Jennifer Brea’s documentary, filmed largely from her own bed, following her illness and the homebound patients she found around the world. Premiered at Sundance and was shortlisted for an Academy Award. The single best way to understand what this page describes. About the film ↗
Read: The Puzzle Solver (2021), by Tracie White
The story of a severely ill young photographer and his father, Stanford geneticist Ron Davis, racing to solve the illness in his own lab. More on the research it describes ↗
Read: How to Be Sick, by Toni Bernhard
A gentle, practical guide to living inside chronic illness — written for patients and for the caregivers beside them.
Pacing guides: #StopRestPace
#MEAction’s plain-language pacing guides for adults, children, and clinicians. Read the guides ↗
Reference: CDC and NIH on ME/CFS
The official overviews — useful to share with a doctor, an employer, or a family member who wants the facts. CDC ↗ · NIH ↗
Go deeper: MEpedia
The community’s own encyclopedia of ME/CFS — symptoms, history, and research, kept by patients and researchers together. Visit MEpedia ↗
NIH funding (~$13M/year, 2022–24): NIH RCDC figures, summarised in the research notes behind this page; an independent project-by-project count puts the total lower still (~$10.1M in 2024). Both methods are described in the notes.
Underfunding rankings: Mirin et al., Work (2020) and Bonuck et al., Communications Medicine (2026) — different measures, same conclusion.
DecodeME genetics: University of Edinburgh preprint, August 2025 (15,579 cases; eight loci) — not yet peer-reviewed at release.
Long COVID overlap: RECOVER-Adult study (Vernon et al., 2025) and a 2026 review of clinic samples.
Charity details: each organisation’s own site and filings, checked November 17, 2026. Campaign dates (such as OMF’s Triple Giving November) change — the charity’s page is always the current word.
Questions this page leaves open, honestly
A formal named fund in Pat’s honour — at Solve M.E., OMF,
or another charity — has not been set up. Tribute gifts in her
name can be made today through each charity’s own donation
page, but no published minimum or terms for a formal named fund
exist yet; that would take a direct conversation with the charity.
Whether a small site like this one needs any Florida charitable-solicitation
filing is a fact-specific legal question this page does not settle.
This site’s posture is the simplest one available: it informs,
it links, and it never collects — and it should be confirmed
with a Florida nonprofit attorney before anything about that changes.
Nothing here is legal or tax advice. For tax questions about a gift,
the charity you give to is the right place to ask.